Company Filing History:
2 out of 23 
2 out of 1,309 
Years Active: 2007-2010
Title: The Innovations of Charles W. Blackledge
Introduction
Charles W. Blackledge is a notable inventor based in Spring City, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for viral infections. With a total of 2 patents to his name, Blackledge's work has the potential to impact the treatment of hepatitis C and related diseases.
Latest Patents
Blackledge's latest patents focus on benzofuran compounds, which are crucial in the treatment and prophylaxis of hepatitis C viral infections. The first patent describes benzofuran derivatives and analogs, along with compositions that utilize these compounds for treating or preventing viral infections associated with the hepatitis C virus. The second patent also emphasizes novel benzofuran derivatives and their applications in combating viral infections, showcasing Blackledge's commitment to advancing medical science.
Career Highlights
Throughout his career, Charles W. Blackledge has worked with prominent companies in the pharmaceutical industry, including Viropharma Incorporated and Wyeth. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in the field.
Collaborations
Some of Blackledge's notable coworkers include Ashis Kumar Saha and Christopher J. Burns. Their collaborative efforts have further enriched the research environment and fostered innovation in the development of new therapeutic methods.
Conclusion
Charles W. Blackledge's contributions to the field of medicinal chemistry, particularly through his patents on benzofuran compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of hepatitis C and related viral infections.